Clinical Trials on Adenocarcinoma, Scirrhous

Total 9446 results

John Neoptolemos
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest; Deutsches... and other collaborators

Not yet recruiting

Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature

Pancreatic Ductal Adenocarcinoma

Sweden, Germany
Sun Yat-sen University

Recruiting

Neoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction Adenocarcinoma

Esophagogastric Junction Adenocarcinoma

China
Vaccinex Inc.
University of Rochester

Recruiting

Trial of Immunotherapy With Avelumab and Pepinemab As Second Line For Patients With Metastatic Pancreatic Adenocarcinoma

Metastatic Pancreatic Adenocarcinoma

United States
Associazione Italiana per lo Studio del Pancreas
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente; High Research...

Recruiting

Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL) (CASSANDRA)

Pancreas Ductal Adenocarcinoma

Italy
Memorial Sloan Kettering Cancer Center
Johns Hopkins University; Dana-Farber Cancer Institute; Sheba Medical Center; Shaare... and other collaborators

Recruiting

A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma

Pancreatic Ductal Adenocarcinoma

United States, Israel
HiberCell, Inc.
Celldex Therapeutics

Terminated

A Maintenance Therapy Study of Odetiglucan With CDX-1140 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Metastatic Pancreatic Adenocarcinoma

United States
Renmin Hospital of Wuhan University

Completed

First-line Apatinib Combined With Tislelizumab and Chemotherapy for Advanced GC (RENMIN-213)

Advanced Gastric Adenocarcinoma

China
Memorial Sloan Kettering Cancer Center
Bayer; State University of New York - Downstate Medical Center; Queens Cancer...

Active, not recruiting

Regorafenib in Good Performance Status Patients With Newly Diagnosed Metastatic Colorectal Adenocarcinoma

Metastatic Colorectal Adenocarcinoma

United States
Cancer Insight, LLC
Bristol-Myers Squibb; Cancer Research Institute, New York City; Akamis Bio

Active, not recruiting

Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma (REVOLUTION)

Metastatic Pancreatic Adenocarcinoma

United States
Theodor Bilharz Research Institute

Completed

Synergistic Immunomodulatory Effect of Synbiotics Pre and Postoperative Resection of Pancreatic Ductal Adenocarcinoma (PDAC)

Pancreatic Ductal Adenocarcinoma

Egypt
UNICANCER
Ferring Pharmaceuticals

Active, not recruiting

Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy (GETUG-AFU22)

Adenocarcinoma of Prostate

France
Centre hospitalier de l'Université de Montréal...

Suspended

A Clinical Study of EUS-RFA for Inoperable Pancreatic Ductal Adenocarcinoma (EUS-RFA)

Pancreatic Ductal Adenocarcinoma

Canada
Ruijin Hospital

Active, not recruiting

Should a Standard Lymphadenectomy Include the No. 16 Lymph Nodes for Patients With Pancreatic Head Adenocarcinoma.

Pancreatic Ductal Adenocarcinoma

China
Spanish Cooperative Group for the Treatment of...

Completed

Phase I/II Study of Nab-paclitaxel and Gemcitabine Followed by AG-mFOLFOX in Patients With Metastatic Pancreatic Adenocarcinoma (SEQUENCE)

Metastatic Pancreatic Adenocarcinoma

Spain
Michele Reni

Active, not recruiting

Chlorambucil in Metastatic PDAC Patients Bearing a Germ Line DNA Defects Repair Mutations (SALE Trial) (SALE)

Pancreatic Ductal Adenocarcinoma

Italy
Hunan Cancer Hospital

Completed

Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC

Metastatic Colorectal Adenocarcinoma

China
Yonsei University

Completed

PI3Kβ Selective Inhibitor With Paclitaxel, Advanced Gastric Adenocarcinoma

Advanced Gastric Adenocarcinoma

Korea, Republic of
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma. (GABRINOX)

Metastatic Pancreatic Adenocarcinoma

France
Pharmacyclics LLC.

Completed

Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE)

Metastatic Pancreatic Adenocarcinoma

Spain, Italy, Korea, Republic of, United States, Belgium, United Kingdom, Germany, France
Hebei Medical University

Unknown

Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy for Gastroesophageal Junction

Gastroesophageal Junction Adenocarcinoma

China
Georgetown University
Novartis; University of Texas Southwestern Medical Center; Cedars-Sinai Medical... and other collaborators

Unknown

LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy

Metastatic Pancreatic Adenocarcinoma

United States
Oncolytics Biotech

Completed

Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

United States
Central Hospital, Nancy, France

Completed

Mechanisms of Cancerogenesis of Woodworkers Adenocarcinomas (ADK-FO)

Ethmoid Sinus Adenocarcinoma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Trial Evaluating Combined Chemotherapy in Patients With Metastatic Pancreatic Adenocarcinoma (GATE 1)

Metastatic Pancreatic Adenocarcinoma

France
Lisa Bax
Roche Pharma AG; Genentech, Inc.

Terminated

Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS) (HIPPoS)

Pancreatic Ductal Adenocarcinoma

United Kingdom
Hospital Universitari de Bellvitge

Completed

Study of Two Techniques of Rectal Reservoir in Low Anterior Resection of Rectum

Low Rectal Adenocarcinoma
Far Eastern Memorial Hospital

Unknown

Mutation Analysis and Copy Number Changes of KRAS and BRAF Gene in Taiwanese Cases of Biliary Tact Adenocarcinoma

Biliary Tract Adenocarcinoma

Taiwan
Memorial Sloan Kettering Cancer Center

Completed

Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations

Oligometastatic Lung Adenocarcinoma

United States
Chinese PLA General Hospital

Unknown

A+C in Metastatic Lung Adenocarcinoma Cancer

Lung Adenocarcinoma Metastatic

China
Zhejiang Cancer Hospital

Unknown

A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC)

Colorectal Cancer

China
Thomas Jefferson University
Context Therapeutics Inc.

Active, not recruiting

Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer

Refractory Endometrial Carcinoma | Refractory Endometrial Endometrioid Adenocarcinoma | Refractory Endometrial Adenocarcinoma | Refractory Endometrial Clear Cell Adenocarcinoma | Refractory Endometrial Mixed Cell Adenocarcinoma | Refractory Endometrial Serous Adenocarcinoma | Refractory Endometrial...

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater Adenocarcinoma

Small Intestinal Adenocarcinoma | Stage III Small Intestinal Adenocarcinoma AJCC v8 | Stage IIIA Small Intestinal Adenocarcinoma AJCC v8 | Stage IIIB Small Intestinal Adenocarcinoma AJCC v8 | Stage IV Small Intestinal Adenocarcinoma AJCC v8 | Ampulla of Vater Adenocarcinoma | Stage III Ampulla... and other conditions

United States
National Cancer Institute (NCI)

Active, not recruiting

Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer

Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IV Gastric Cancer AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction... and other conditions

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Metastatic Gastroesophageal Junction Adenocarcinoma | Unresectable Gastroesophageal Junction Adenocarcinoma | Metastatic Malignant Neoplasm in the Brain and other conditions

United States
Endocyte

Completed

Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03)

Adenocarcinoma of the Lung
Istituto Oncologico Veneto IRCCS

Recruiting

ImmunoNutrition and Colorectal Adenocarcinoma Surgery - INCAS Study (INCAS)

Colorectal Adenocarcinoma

Italy
China Medical University, China

Not yet recruiting

Cadonilimab+ Paclitaxel (Albumin-bound) Treat Advanced Gastric Adenocarcinoma With PD-(L)1 Inhibitors Resistance

Gastric Adenocarcinoma
Fondazione Poliambulanza Istituto Ospedaliero
Associazione Italiana per la Ricerca sul Cancro

Recruiting

The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer. (ADAPTA)

Ampullary Adenocarcinoma

Italy
Cancer Trials Ireland

Recruiting

Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas)

Pancreatic Adenocarcinoma

Ireland
Tongji Hospital
Shanxi Province Cancer Hospital; Chongqing University Cancer Hospital; Fudan... and other collaborators

Not yet recruiting

Comparing Laparoscopic and Open Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas (NPPC)

Periampullary Adenocarcinoma

China
GERCOR - Multidisciplinary Oncology Cooperative...

Recruiting

Prognostic and Predictive Markers of Treatment Response in Patients With PAC. (CANOPE)

Pancreatic Adenocarcinoma

France
Medical College of Wisconsin
Barbara Ann Karmanos Cancer Institute; Cornerstone Pharmaceuticals

Recruiting

CPI-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Adenocarcinoma

Pancreas Adenocarcinoma

United States
Sohag University

Recruiting

Immunohistochemical Expression of PD-L1 in Pancreatic Ductal Adenocarcinoma

Pancreatic Adenocarcinoma

Egypt
Medical College of Wisconsin

Recruiting

Circulating Tumor DNA (ctDNA) in Locally Advanced Esophageal and Gastroesophageal (GE) Junction Adenocarcinoma (TRACT DNA)

Adenocarcinoma Esophagus

United States
Capital Health System, Inc

Recruiting

Safety of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma

Pancreas Adenocarcinoma

United States
Memorial Sloan Kettering Cancer Center
Illuminare Biotechnologies

Recruiting

Fluorescent Imaging of Nerves With Illuminare-1 During Surgery

Prostate Adenocarcinoma

United States
Medical College of Wisconsin

Recruiting

MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer

Rectal Adenocarcinoma

United States
Federation Francophone de Cancerologie Digestive

Recruiting

Survival and Description of Care for Patients With Degenerate Vaterian Ampulloma (AMPULLOMA)

Ampullary Adenocarcinoma

France
Tata Memorial Centre
Tata Medical Center

Recruiting

Prostate Radiotherapy Comparing Moderate and Extreme Hypo-fractionation (PRIME Trial) (PRIME)

Prostate Adenocarcinoma

India
Institut für Klinische Krebsforschung IKF GmbH...
Merck Sharp & Dohme LLC; Organon Healthcare GmbH

Active, not recruiting

Evaluating Pembrolizumab, Trastuzumab and FLOT as Perioperative Treatment of HER2-positive, Localized Esophagogastric Adenocarcinoma

Esophagogastric Adenocarcinoma

Germany

Clinical Trials on Adenocarcinoma, Scirrhous

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations